Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;31(4):504-13.
doi: 10.1039/c3np70076c. Epub 2014 Feb 11.

Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition

Affiliations
Review

Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition

Anne-Marie R Dechert-Schmitt et al. Nat Prod Rep. 2014 Apr.

Abstract

Despite the longstanding importance of polyketide natural products in human medicine, nearly all commercial polyketide-based drugs are prepared through fermentation or semi-synthesis. The paucity of manufacturing routes involving de novo chemical synthesis reflects the inability of current methods to concisely address the preparation of these complex structures. Direct alcohol C-H bond functionalization via"C-C bond forming transfer hydrogenation" provides a powerful, new means of constructing type I polyketides that bypasses stoichiometric use of chiral auxiliaries, premetallated C-nucleophiles, and discrete alcohol-to-aldehyde redox reactions. Using this emergent technology, total syntheses of 6-deoxyerythronolide B, bryostatin 7, trienomycins A and F, cyanolide A, roxaticin, and formal syntheses of rifamycin S and scytophycin C, were accomplished. These syntheses represent the most concise routes reported to any member of the respective natural product families.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative polyketide natural products isolated from soil bacteria used in human medicine.
Figure 2
Figure 2
General catalytic mechanism and survey of selected bond lengths from a series of π-allyliridium C,O-benzoate complexes.
Scheme 1
Scheme 1
Enantioselective iridium catalyzed alcohol C-H allylation.a aI = (R)-Cl,MeO-BIPHEP, II = (R)-TMBTP, III = (R)-BINAP
Scheme 2
Scheme 2
Generation of polyacetate substructures via 1- and 2-directional chain elongation.
Scheme 3
Scheme 3
Asymmetric iridium catalyzed C-H allylation of chiral β-stereogenic alcohols.
Scheme 4
Scheme 4
Enantioselective iridium catalyzed alcohol C-H crotylation.
Scheme 5
Scheme 5
Total synthesis of the oxo-polyene macrolide (+)-roxaticin.
Scheme 6
Scheme 6
Asymmetric double anti-crotylation of 2-methyl-1,3-propanediol: formal syntheses of rifamycin S and scytophycin C.
Scheme 7
Scheme 7
Ruthenium catalyzed syn-diastereo- and enantioselective crotylation via hydrohydroxyalkylation of 2-silyl-butadienes. a Chiral Ligand = (R)-DM-SEGPHOS. b Chiral Ligand = (R)- SEGPHOS.
Scheme 8
Scheme 8
Total syntheses of trienomycins A and F via ruthenium catalyzed syn-diastereo- and enantioselective hydrohydroxyalkylation of 2-silyl-butadienes.
Scheme 9
Scheme 9
Inversion of diastereoselectivity in enantioselective ruthenium catalyzed crotylation via butadiene hydrohydroxyalkylation.
Scheme 10
Scheme 10
Total synthesis of 6-deoxyerythronlide B via diastereo- and enantioselective alcohol C-H crotylation.
Scheme 11
Scheme 11
Enantioselective iridium catalyzed alcohol C-H reverse prenylation.
Scheme 12
Scheme 12
Total synthesis of bryostatin 7 via C-C bond forming hydrogenation and transfer hydrogenation.
Scheme 13
Scheme 13
Total synthesis of cyanolide A via enantioselective double allylation of neopentyl glycol.

References

    1. For selected reviews on polyketide natural products, see: O’Hagan D. The Polyketide Metabolites. Ellis Horwood; Chichester: 1991. Rimando AM, Baerson SR. ACS Symposium Series 955. American Chemical Society; 2007. Polyketides Biosynthesis, Biological Activity, and Genetic Engineering.

    1. Newman DJ, Cragg GM. J Nat Prod. 2007;70:461. - PubMed
    2. Newman DJ, Grothaus PG, Cragg GM. Chem Rev. 2009;109:3012. - PubMed
    1. Rohr J. Angew Chem Int Ed. 2000;39:2847. - PubMed
    1. Isolation of erythromycin A: McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, Smith JW. Antibiot Chemother. 1952;2:281.

    1. Isolation of amphotericin B: Vandeputte J, Watchtel JL, Stiller ET. Antibior Annu. 1956:587.<underline>X-ray structure</underline>: Mechinski W, Shaffner CP, Ganis P, Avitabile G. Tetrahedron Lett. 1970;11:3873.Ganis P, Avitabile G, Mechinski W, Shaffner CP. J Am Chem Soc. 1971;93:4560.

Publication types

MeSH terms

LinkOut - more resources